Major Milestone For SK Biopharm As Anti-Epileptic Gets US Approval

 
• By Jung Won Shin
MRI
SK's New Treatment Option For Refractory Epilepsy To Launch In 2020 • Source: Shutterstock

More from New Products

More from Scrip